Atlas Trials

Prostatic Hyperplasia

142 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Prostatic Hyperplasia

RecordFirmDate
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems (NCT00547625)Eli Lilly and Company2004-10-01
Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) (NCT02244346)Boehringer Ingelheim2004-05-01
Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) (NCT02244333)Boehringer Ingelheim2004-02-01
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment (NCT00090103)GlaxoSmithKline2003-11-01
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels (NCT00062790)GlaxoSmithKline2003-10-01
Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia (NCT00969072)GlaxoSmithKline2003-08-01
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms (NCT02245490)Boehringer Ingelheim2003-01-01
Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) (NCT02244320)Boehringer Ingelheim2002-09-01
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). (NCT00044226)Milkhaus Laboratory2002-04-01
Clinical Trial in Males With BPH (Enlarged Prostate) (NCT00029822)Sanofi2001-05-01
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH (NCT00290030)Sanofi2001-05-01
Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia (NCT02244268)Boehringer Ingelheim2000-10-01
Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade (NCT02244307)Boehringer Ingelheim2000-01-01
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia (NCT02244255)Boehringer Ingelheim1998-08-01
Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT02244242)Boehringer Ingelheim1998-07-01
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients (NCT02244229)Boehringer Ingelheim1998-04-01
Medical Therapy of Prostatic Symptoms (NCT00021814)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1995-12-01
← Previous

Track Prostatic Hyperplasia automatically

Every clearance here is in the API, with alerts when new ones post.